Cell Medica Company Profile

09:36 EDT 21st March 2019 | BioPortfolio

Cell Medica is a clinical stage cellular therapeutics company engaged in the development and delivery of cellular immunotherapy treatment strategies for infectious disease and cancer. The Company’s lead clinical application, referred to as Virus-Specific Immune Reconstitution (VSIR), involves the transfer of donor-derived virus-specific T cells into a patient in order to prevent infections following allogeneic hematopoietic stem cell (bone marrow) transplant. The Company is currently sponsoring a confirmatory (Phase III style) clinical trial for VSIR across 14 bone marrow transplant centers in the UK.

News Articles [1337 Associated News Articles listed on BioPortfolio]

Cell Medica given $8.7 million to develop cancer therapy

Cell Medica has been awarded a $8.7 million CPRIT grant to accelerate its CMD-502 cell therapy into clinical development.

Cell Medica: Transforming patients live through cellular immunotherapy

Cell Medica is committed to transforming the treatment of cancer through the use of cellular immunotherapy. Through our internal development and collaborations and with leading academic research grou...

First neuroblastoma patient successfully dosed with innovative CAR therapy utilizing natural killer T cells (CAR-NKT)

Cell Medica announces the treatment of the first patient world-wide to receive CMD-501, an autologous CAR-NKT therapy targeting pediatric neuroblastoma. This is the first time an engineered NKT cell t...

Cell Medica Awarded $8.7M CPRIT Grant to Accelerate CMD-502 Off-the-shelf CAR-NKT Cell Therapy into Clinical Development …

Cell Medica Awarded $8.7M CPRIT Grant to Accelerate CMD-502 Off-the-shelf CAR-NKT Cell Therapy into Clinical Development

Cell Medica doses first neuroblastoma patient with NK cell therapy

Cell Medica receives US$8.7 million for cell therapy pipeline project

A cancer research institute in Texas has awarded a grant to accelerate off-the-shelf CAR-NKT cell therapy into clinical development

GenePlanet Presents its Innovative Health Platform at MEDICA 2018

GenePlanet, the Swiss-backed biotech company present in more than 30 countries worldwide, is attending MEDICA, the leading international trade fair for the medical sector that takes place in Düsseldo...

MEDICA 2018: The Starting Block for Many Start-Ups

12 - 15 November 2018, Düsseldorf, Germany. MEDICA, the world’s leading medical trade fair in Düsseldorf which attracts over 5,000 exhibitors from around 70 countries, is becoming an even bigger ...

Drugs and Medications [10 Associated Drugs and Medications listed on BioPortfolio]

Bioelements [bioelements]

Active Astringent

Concept dha [us pharmaceutical corporation]

see all prescribing information for Concept DHA

Tandem [us pharmaceutical corporation]

see all prescribing information for Tandem

Tandem ob [us pharmaceutical corporation]

see all prescribing information for Tandem OB

Tandem dha [us pharmaceutical corporation]

see all prescribing information for Tandem DHA

PubMed Articles [2905 Associated PubMed Articles listed on BioPortfolio]

The Costly War Against Cancer Treatment: The Example of Metastatic Renal Cell Carcinoma in Portugal.

Cytotoxic Prenylated Xanthones from the Leaves of Garcinia bracteata.

Six new prenylated xanthones (1: -6: ) and seventeen known xanthones were isolated from extracts of leaves. Their structures were determined by extensive NMR and MS spectroscopic data analysis. The i...

Concomitant radiotherapy and TKI in metastatic EGFR- or ALK-mutated non-small cell lung cancer: a multicentric analysis on behalf of AIRO lung cancer study group.

To investigate the role of radiotherapy (RT) in the management of EGFR- or ALK-mutated metastatic non-small cell lung cancer (NSCLC) treated with TKI.

Single center evidence for the treatment of basal cell carcinoma of the head and neck.

Basal Cell Carcinoma (BCC) alone accounts for 80% of cases of non-melanoma skin cancer (NMSC), which characteristically develops on sun-exposed skin. Indeed the most common site of BCC is the head and...

New Cytotoxic Cycloartane Triterpenes from the Aerial Parts of Actaea heracleifolia (syn. Cimicifuga heracleifolia).

One new 15,16-seco-cycloartane triterpene (1: ), three new cycloartane triterpene glycosides (2: -4: ), and five known compounds (5: -9: ) were isolated from the aerial parts of The chemical structur...

Clinical Trials [6756 Associated Clinical Trials listed on BioPortfolio]

The Evaluation of Point of Care Testing for Determining Hemoglobin Levels in Geriatric Intensive Care Patients

The aim of the present study was to compare hemoglobin (Hb) levels determined by point of care testing HemaCue and arterial blood gas analyzer with an automated hematology analyzer in crit...

Cardiovascular-Protective Effects of Herbal Medicine Danshen-Gegen

Atherosclerosis (in particular stroke and heart attack) is the most important health issue in modernized society and high blood pressure is an important predisposing factor. Hypertensive s...

Bioequivalence Study of 120 mg Etoricoxib Film-coated Tablets

The present study was a randomized, open-label, two-period, two-sequence, cross-over study, conducted to find out whether the etoricoxib 120 mg film-coated tablet produced by PT Dexa Medic...

Different Types of Electrostimulation Probes During IONM

Intraoperative nerve monitoring is often used in many centers during thyroidectomy. According to the investigators' knowledge, there's no study showing superiority between bipolar and mono...

Phase I Single-dose Escalation Clinical Trial of Salvianolic Acid A Tablets

Salvianolic acid A has a variety of pharmacological effects, such as: anti-oxidation, scavenging oxygen free radicals, anti-fibrosis, anti-myocardial ischemia, anti-coagulation, anti-throm...

Companies [1027 Associated Companies listed on BioPortfolio]

Cell Medica Limited

Cell Medica is a cellular therapeutics company engaged in the development, manufacturing and marketing of T cell immunotherapy approaches for the treatment of infections and cance...

Medica Corporation

Medica Corporation manufactures and sells in vitro diagnostic medical devices including electrolyte and blood gas analyzers, chemistry analyzers, and hematology analyzers. Medica ...

ASTA Medica GmbH

Wellcome to ASTA Medica In the course of the restructuring process of ASTA Medica, the business units AWD.pharma, Oncology and VIATRIS (Health Products) have been sold to other pharmaceutical companie...

The Medica Foundation

The Medica Foundation is a non-profit, charitable grant-making foundation. The foundation’s service area currently includes the states of Minnesota, North Dakota, South Dakot...

International Medica Foundation

The International Medica Foundation, which has the rights to RotaShield, is a nonprofit foundation that focuses on ensuring that a safe, effective and affordable rotavirus ...

More Information about "Cell Medica" on BioPortfolio

We have published hundreds of Cell Medica news stories on BioPortfolio along with dozens of Cell Medica Clinical Trials and PubMed Articles about Cell Medica for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cell Medica Companies in our database. You can also find out about relevant Cell Medica Drugs and Medications on this site too.

Quick Search


Relevant Topics

Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...

Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Corporate Database Quicklinks

Searches Linking to this Company Record